Although, a positive trend in PFS and OS was observed in PD-L1-positive patients, suggesting a role of T-DM1 in eliciting anti-tumor immunity and acting as a primer to sensitize tumors to immune checkpoint inhibitors [ 41 ].
← all excerpts
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy.
1
—
—